An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR) agonist that mimics the effects of ...
A team from Atrogi AB has reported the activity of ATR-127, a novel dual adrenergic agonist targeting β2- and β3-adrenoceptors (ARs), for the potential treatment of steatohepatitis, obesity and ...
SAN CARLOS, Calif.--(BUSINESS WIRE)--CuraSen Therapeutics, Inc., a privately held, clinical-stage biotechnology company, announced Phase 1 proof-of-principle data demonstrating that salbutamol, a drug ...
image: Stephen Liggett, MD, of the University of South Florida Health (USF Health) led a multi-institutional research team that studied 40 million compounds to identify those that activated beta-2 ...
Prognostic value of circulating tumor DNA fraction (TF) for patients with metastatic renal cell carcinoma (mRCC). Effect of cytoreductive nephrectomy on the efficacy of immunotherapy in metastatic ...
A ready-to-use premixed formulation of Adrenalin ® (epinephrine in 0.9% sodium chloride injection) has been made available by Endo, Inc. Adrenalin is a non-selective alpha and beta adrenergic agonist ...
O.G. Shcherbakova et al., "Organization of β-adrenoceptor signaling compartments by sympathetic innervation of cardiac myocytes," J Cell Biol, 176:521-33, Feb. 12, 2007. The authors work suggests that ...
In a small study, add-on vibegron appeared well-tolerated and clinically effective among men with persistent OAB. Vibegron add-on therapy is both safe and effective for men with persistent storage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback